M.B.H. Youdim
- Neurology top 2%
- Parkinson's Disease Mechanisms and Treatments 14
- Neurological disorders and treatments 5
- Neurological diseases and metabolism 2
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments 14
- Neurological disorders and treatments 5
- Neurological diseases and metabolism 2
- Hematology top 5%
- Nutrition and Dietetics top 5%
-
- Neurological and metabolic disorders 6
-
- Metabolism and Genetic Disorders 5
-
- Diet and metabolism studies 3
-
- RNA regulation and disease 2
-
- Cholinesterase and Neurodegenerative Diseases 2
M.B.H. Youdim
28 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Neurology 676
- Neurology 266
- Cellular and Molecular Neuroscience 365
- Hematology 163
- Nutrition and Dietetics 200
Countries citing papers authored by M.B.H. Youdim
This map shows the geographic impact of M.B.H. Youdim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.B.H. Youdim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.B.H. Youdim more than expected).
Fields of papers citing papers by M.B.H. Youdim
This network shows the impact of papers produced by M.B.H. Youdim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.B.H. Youdim. The network helps show where M.B.H. Youdim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M.B.H. Youdim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 0 | |
| 2 | My love with monoamine oxidase, iron and Parkinson's disease. | 2006 | 5 |
| 3 | 2000 | 79 | |
| 4 | 2000 | 83 | |
| 5 | Anti-apoptotic function of L-(-)deprenyl (Selegiline) and related compounds. | 2000 | 12 |
| 6 | 2000 | 98 | |
| 7 | 1999 | 37 | |
| 8 | 1999 | 72 | |
| 9 | MPTP-Induced Parkinsonian Syndrome | 1999 | 11 |
| 10 | Drug- Or Toxin-Induced Movement Disorders | 1999 | 1 |
| 11 | Amyotrophic Lateral Sclerosis—Parkinsonism—Dementia of Guam | 1999 | 1 |
| 12 | 1995 | 7 | |
| 13 | 1993 | 20 | |
| 14 | 1993 | 10 | |
| 15 | Iron and ferritin in substantia nigra in Parkinson's disease. | 1993 | 67 |
| 16 | 1990 | 9 | |
| 17 | Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brainbreakdown → | 1988 | 591 |
| 18 | Minimal brain damage induced by early iron deficiency: modified dopaminergic neurotransmission. | 1987 | 26 |
| 19 | Prevention of 1 methyl 4 phenyl 1 2 3 6 tetrahydropyridine induced neurotoxicity by agn 1133 and agn 1135 selective inhibitors of monoamine oxidase b | 1985 | 1 |
| 20 | 1974 | 4 |
About M.B.H. Youdim
M.B.H. Youdim is a scholar working on Neurology, Clinical Biochemistry and Neurology, having authored 29 papers that have together received 1.3k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (14 papers), Neurological and metabolic disorders (6 papers), Metabolism and Genetic Disorders (5 papers), Neurological disorders and treatments (5 papers), Diet and metabolism studies (3 papers), Neurological diseases and metabolism (2 papers), RNA regulation and disease (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). The work is most often cited by research in Neurology (676 citations), Neurology (266 citations) and Cellular and Molecular Neuroscience (365 citations). M.B.H. Youdim has collaborated with scholars based in Israel, Germany and Austria. Frequent co-authors include Peter Riederer, G. Hebenstreit, Gavin P. Reynolds, Helmut Heinsen, H. Beckmann, E. Sofić, M. Gerlach, Shlomo Yehuda, Dorit Ben‐Shachar and J. Sian. Their work appears in journals such as Journal of Neural Transmission, Movement Disorders, European Journal of Pharmacology, Pharmacological Research and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.